UK diarrhea sufferers can now access digital support to manage their gut health thanks to a mobile app extension from Kenvue to its UK Imodium range.
Kenvue Joins Digital Gut Health Revolution With UK Imodium App
Kenvue’s new Gut2Know app “empowers diarrhea sufferers to boost their gut knowledge and track and identify triggers for their symptoms, such as stress or diet,” the company says. With the launch, Kenvue joins other major players like Bayer and Sanofi who have recently invested in digital digestive health.
More from United Kingdom
PAGB CEO Michelle Riddalls and ISF president emeritus David Webber have been awarded OBEs for their services to consumer health and self-care.
A recent Kenvue survey shows that an overwhelming majority of UK pharmacists believe many health issues could be prevented through better self-care.
FSA now aims to send the first recommendations for the authorization of CBD novel food products to UK government ministers in 2025, according to its most recent board meeting. The agency is closely scrutinizing trace THC levels and is planning to ban use of CBD food products by under 18s.
The trophies have been presented at the OTC Marketing Awards 2024 - but what did the judging panel have to say about the winning and highly-commended entries?
More from Europe
Bayer Consumer Health snaps up digital therapeutic Cara Care for its Precision Health business with an eye to developing its self-care capabilities.
FSA now aims to send the first recommendations for the authorization of CBD novel food products to UK government ministers in 2025, according to its most recent board meeting. The agency is closely scrutinizing trace THC levels and is planning to ban use of CBD food products by under 18s.
Bayer Consumer Health shelves European launch of topical OTC onychomycosis treatment under its Canesten brand after a Phase III trial of the product - developed by Sweden's Moberg Pharma - failed to meet its primary endpoint.